These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 12708488)

  • 1. Renal carcinogenesis: genotype, phenotype and dramatype.
    Hino O; Kobayashi T; Momose S; Kikuchi Y; Adachi H; Okimoto K
    Cancer Sci; 2003 Feb; 94(2):142-7. PubMed ID: 12708488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary renal carcinogenesis fitting Knudson's two-hit model: genotype, environment, and phenotype.
    Hino O
    Genes Chromosomes Cancer; 2003 Dec; 38(4):357-67. PubMed ID: 14566856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cancer genetics of TSC2 gene mutant(Eker) rat model].
    Hino O
    Nihon Rinsho; 2000 Jun; 58(6):1255-61. PubMed ID: 10879050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multistep renal carcinogenesis in the Eker (Tsc 2 gene mutant) rat model.
    Hino O
    Curr Mol Med; 2004 Dec; 4(8):807-11. PubMed ID: 15579027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of the neoplastic phenotype by replacement of the Tsc2 gene in Eker rat renal carcinoma cells.
    Orimoto K; Tsuchiya H; Kobayashi T; Matsuda T; Hino O
    Biochem Biophys Res Commun; 1996 Feb; 219(1):70-5. PubMed ID: 8619830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and environmental factors in hereditary predisposition to tumors: a conceptual overview.
    Hino O; Kobayashi T; Okimoto K
    EXS; 2006; (96):269-92. PubMed ID: 16383022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multistep renal carcinogenesis as gene expression disease in tumor suppressor TSC2 gene mutant model--genotype, phenotype and environment.
    Hino O; Majima S; Kobayashi T; Honda S; Momose S; Kikuchi Y; Mitani H
    Mutat Res; 2001 Jun; 477(1-2):155-64. PubMed ID: 11376696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of potent transcriptional activation domains in the predisposing tuberous sclerosis (Tsc2) gene product of the Eker rat model.
    Tsuchiya H; Orimoto K; Kobayashi K; Hino O
    Cancer Res; 1996 Feb; 56(3):429-33. PubMed ID: 8564946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TSC2 gene mutant (Eker) rat model of a Mendelian dominantly inherited cancer.
    Hino O; Fukuda T; Satake N; Kobayashi T; Honda S; Orimoto K; Yamashita Y; Kikuchi Y
    Prog Exp Tumor Res; 1999; 35():95-108. PubMed ID: 10377754
    [No Abstract]   [Full Text] [Related]  

  • 10. Transgenic rescue from embryonic lethality and renal carcinogenesis in the Eker rat model by introduction of a wild-type Tsc2 gene.
    Kobayashi T; Mitani H; Takahashi R; Hirabayashi M; Ueda M; Tamura H; Hino O
    Proc Natl Acad Sci U S A; 1997 Apr; 94(8):3990-3. PubMed ID: 9108092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary renal cell carcinoma in the Eker rat: a unique animal model for the study of cancer susceptibility.
    Everitt JI; Goldsworthy TL; Wolf DC; Walker CL
    Toxicol Lett; 1995 Dec; 82-83():621-5. PubMed ID: 8597118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular genetic basis of renal carcinogenesis in the Eker rat model of tuberous sclerosis (Tsc2).
    Hino O; Kobayashi E; Hirayama Y; Kobayashi T; Kubo Y; Tsuchiya H; Kikuchi Y; Mitani H
    Mol Carcinog; 1995 Sep; 14(1):23-7. PubMed ID: 7546221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mourning Dr. Alfred G. Knudson: the two-hit hypothesis, tumor suppressor genes, and the tuberous sclerosis complex.
    Hino O; Kobayashi T
    Cancer Sci; 2017 Jan; 108(1):5-11. PubMed ID: 27862655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of the Nihon rat model of BHD.
    Okimoto K; Kouchi M; Matsumoto I; Sakurai J; Kobayashi T; Hino O
    Curr Mol Med; 2004 Dec; 4(8):887-93. PubMed ID: 15579036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of a modifier gene(s) affecting early renal carcinogenesis in the Tsc2 mutant (Eker) rat model.
    Kikuchi Y; Sudo A; Mitani H; Hino O
    Int J Oncol; 2004 Jan; 24(1):75-80. PubMed ID: 14654943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A germline insertion in the tuberous sclerosis (Tsc2) gene gives rise to the Eker rat model of dominantly inherited cancer.
    Kobayashi T; Hirayama Y; Kobayashi E; Kubo Y; Hino O
    Nat Genet; 1995 Jan; 9(1):70-4. PubMed ID: 7704028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberous sclerosis gene products in proliferation control.
    Hengstschläger M; Rodman DM; Miloloza A; Hengstschläger-Ottnad E; Rosner M; Kubista M
    Mutat Res; 2001 Jul; 488(3):233-9. PubMed ID: 11397651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of cyclooxygenase-2 expression but up-regulation of cyclooxygenase-1 in renal carcinomas of the Eker (TSC2 gene mutant) rat model.
    Okamoto T; Hara A; Hino O
    Cancer Sci; 2003 Jan; 94(1):22-5. PubMed ID: 12708469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene.
    Yeung RS; Xiao GH; Jin F; Lee WC; Testa JR; Knudson AG
    Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11413-6. PubMed ID: 7972075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal carcinogenesis in the Eker rat.
    Hino O; Kobayashi E; Nishizawa M; Kubo Y; Kobayashi T; Hirayama Y; Takai S; Kikuchi Y; Tsuchiya H; Orimoto K
    J Cancer Res Clin Oncol; 1995; 121(9-10):602-5. PubMed ID: 7559744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.